An Origin Partner, Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is the Director and Professor at the Utah Tech University Center for Precision Medicine and Functional Genomics and a Precision Medicine Advisor at the Geriatric Oncology Consortium. He has conducted and/or advised implementation of precision medicine programs at integrated health systems, academic medical centers, and community practices in the USA and Internationally. Dr McLeod was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He was recently recognized as #1 USA/#2 Global for Pharmacogenomics Expertise. He has partnered with Origin on numerous projects over the past decade, primarily with a precision oncology focus. Howard has published over 600 peer reviewed papers on precision medicine, pharmacogenomics, or cancer pharmacology with collaborators from over 40 countries. He continues to work to advance cutting-edge healthcare and early adoption of high impact innovation.